LONDON BROKER RATINGS: Experian on JPMorgan focus list at 'overweight'
(Alliance News) - The following London-listed shares received analyst recommendations on Thursday morning and on Wednesday: Read More
| Price | 356.80p on 18-02-2026 at 16:03:44 |
|---|---|
| Change | 2.00p 0.56% |
| Buy | 357.20p |
| Sell | 356.60p |
| Last Trade: | Sell 256.00 at 356.80p |
| Day's Volume: | 397,554 |
| Last Close: | 354.80p |
| Open: | 356.80p |
| ISIN: | GB00BM8NFJ84 |
| Day's Range | 350.60p - 357.00p |
| 52wk Range: | 300.00p - 501.00p |
| Market Capitalisation: | £1.24b |
| VWAP: | 352.5738p |
| Shares in Issue: | 346.68m |
Breedon (BREE) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 256 | 356.80p | Automatic Execution |
16:03:43 - 18-Feb-26 |
| Sell* | 241 | 356.80p | Automatic Execution |
16:03:43 - 18-Feb-26 |
| Sell* | 750 | 356.80p | Automatic Execution |
16:01:08 - 18-Feb-26 |
| Sell* | 256 | 356.80p | Automatic Execution |
16:01:08 - 18-Feb-26 |
| Sell* | 13 | 356.80p | Automatic Execution |
16:01:08 - 18-Feb-26 |
| Sell* | 221 | 357.00p | Automatic Execution |
16:01:03 - 18-Feb-26 |
| Buy* | 444 | 357.00p | Automatic Execution |
15:59:22 - 18-Feb-26 |
| Buy* | 256 | 357.00p | Automatic Execution |
15:59:22 - 18-Feb-26 |
| Sell* | 500 | 356.60p | Automatic Execution |
15:59:10 - 18-Feb-26 |
| Sell* | 310 | 356.50p | SI Trade |
15:58:51 - 18-Feb-26 |
Breedon (BREE) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 11th Feb 2026 4:01 pm | RNS | Issue of Shares |
| 30th Jan 2026 12:44 pm | RNS | Block Listing Update |
| 30th Jan 2026 7:00 am | RNS | Notice of Annual Results 2025 |
| 31st Dec 2025 7:00 am | RNS | BLOCK LISTING SIX MONTHLY RETURN |
| 31st Dec 2025 7:00 am | RNS | Total Voting Rights |
| 2nd Dec 2025 3:49 pm | RNS | Director/PDMR Shareholding |
| 28th Nov 2025 3:29 pm | RNS | Director/PDMR Shareholding |
| 28th Nov 2025 8:55 am | RNS | Total Voting Rights |
| 26th Nov 2025 5:20 pm | RNS | Director/PDMR Shareholding |
| 21st Nov 2025 7:00 am | RNS | Director/PDMR Shareholding |